Companies Dominating the Bioresorbable Collagen Implant Landscape
- Allergan, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Zimmer Biomet Holdings, Inc.
- Galderma S.A.
- CollPlant Holdings Ltd.
- Collagen Matrix, Inc.
- Merz Pharma GmbH & Co. KGaA
- RegenLab SA
- Croma-Pharma GmbH
- Dr. Suwelack AG & Co. KG
- Mentor Worldwide LLC
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of bioresorbable collagen implant is assessed at USD 1.38 billion.
The bioresorbable collagen implant market size was valued at USD 1.29 billion in 2024 and is expected to reach USD 3.59 billion by 2037, registering around 8.2% CAGR during the forecast period i.e., between 2025-2037. Increasing demand for healthcare will fuel the market growth.
Asia Pacific industry is predicted to hold largest revenue share of 37% by 2037, impelled by high incidence of trauma cases in the region.
The major players in the market are Allergan, Inc., Zimmer Biomet Holdings, Inc., Galderma S.A., CollPlant Holdings Ltd., Collagen Matrix, Inc., Merz Pharma GmbH & Co. KGaA, and others.
